Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006365
Filing Date
2005-03-14
Accepted
2005-03-14 17:08:12
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2153380z10-k.htm 10-K 709391
2 EXHIBIT 23.1 a2153380zex-23_1.htm EX-23.1 2224
3 EXHIBIT 31.1 a2153380zex-31_1.htm EX-31.1 6141
4 EXHIBIT 31.2 a2153380zex-31_2.htm EX-31.2 6153
5 EXHIBIT 32.1 a2153380zex-32_1.htm EX-32.1 2826
6 EXHIBIT 32.2 a2153380zex-32_2.htm EX-32.2 2838
7 EXHIBIT 99.2 a2153380zex-99_2.txt EX-99.2 7364
8 EXHIBIT 99.3 a2153380zex-99_3.txt EX-99.3 29648
9 EXHIBIT 99.4 a2153380zex-99_4.txt EX-99.4 13044
  Complete submission text file 0001047469-05-006365.txt   782082
Mailing Address 24 EMILY ST CAMBRIDGE MA 02139
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21379 | Film No.: 05679100
SIC: 2834 Pharmaceutical Preparations